HURA
TuHURA Biosciences Inc
2.00$
+1.6%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +32.4% | +9.7% | +0.0% | +18.8% | +0.0% | +0.0% | -38.6% | -31.4% | 0.0% | -43.0% | +75.5% | +0.0% | -44.7% | -35.5% | +0.0% | +1,400.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +128.7% | -50.4% | +70.6% | -39.2% | -20.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +53.0% | -3.1% | +90.0% | -6.3% | +10.7% | -16.9% | -28.3% | -20.2% | -7.1% | -22.3% | +30.4% | -24.8% | -1.3% | +26.2% | +44.4% | +4.6% | +90.4% | +48.7% | +4.9% | -5.9% | +2.9% | -11.0% | +15.3% | -20.8% | -35.1% | -2.6% | +3.5% | -10.5% | -94.0% | +3,133.3% | -97.2% | +2,817.6% | +34.9% | +15.2% | +7.5% | +0.8% | +21.9% | -13.6% | +26.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -21.7% | +146.0% | – | – | -48.0% | +67.9% | -11.3% | +47.1% | -6.7% | – | |
| – | -17.5% | +5.5% | +56.7% | -4.2% | +17.7% | -7.0% | -18.0% | -16.7% | -9.0% | -8.2% | +73.6% | -43.6% | +8.0% | +11.9% | +40.1% | +4.5% | +86.1% | +22.6% | +1.4% | -10.9% | -1.3% | -9.1% | +1.9% | -14.9% | -24.8% | -5.7% | +1.4% | -11.6% | -65.9% | +358.7% | -48.6% | +56.3% | +53.4% | +23.6% | +40.7% | -31.9% | +21.5% | -8.2% | +16.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5.7% | -9.1% | -10.0% | – | – | – | – | – | – | – | – | – | – | – | +432.1% | +47.5% | -73.9% | -100.0% | – | – | +3,582.3% | -95.4% | +1,571.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.